Cardiovascular

Rosuvastatin: No Significant Benefit for Older Patients with Systolic Heart Failure: CORONA Study Results

November 6, 2007 ⋅ Post a comment
Ake Hjalmarson
Ake Hjalmarson
Gordon Tomaselli
Gordon Tomaselli

REFERENCE: Late Breaking Clinical Trials, Session 2, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida
N Engl J Med 2007;357
AKE HJALMARSON, Sahlgrenska University, Göteborg
COMMENT: GORDON TOMASELLI, Johns Hopkins University, Baltimore
The lipid lowering agent rosuvastatin did not bring a significant benefit to older patients with systolic heart failure, according to the findings of the CORONA study released at the American Heart Association sessions in Orlando. Ake Hjalmarson talked with Peter Goodwin about the implications this has for using statins in older patients with heart failure.

Similar Interviews

  • BNP Test: Key Diagnostic Step for Heart Failure (PEP Study)

    • John Cleland Maarten Simoons REFERENCE: Hot Line 1 Sunday 11:00 2 Sept, European Society of Cardiology

  • Audio Journal of Cardiovascular Medicine: September 8th 2006 - Reporting from the World Congress of Cardiology joint meeting with European Society of Cardiology, September 2-6, 2006, Barcelona">Audio Journal of Cardiovascular Medicine: September 8th 2006 - Reporting from the World Congress of Cardiology joint meeting with European Society of Cardiology, September 2-6, 2006, Barcelona

    • Christoph Kaiser

  • Audio Journal of Cardiovascular Medicine 11.1, January 2005

    • Reporting from: American Heart Association Scientific Sessions, New Orleans, November 7-10, 2004 In this edition: In severe heart failure, Teresa De Marco told

    Post a comment

    LDL-How Low?»
    Terje Pedersen, Ulleval University, Oslo
    Lowering LDL Cholesterol intensively as a means of treating aortic stenosis was found to have no benefit in the SEAS (Simvastatin and Ezetimibe In Aortic Stenosis) study reported by Terje Pederson at a Hot Line session of the E.S.C. Congress. But the potential gains from such lowering in other clinical situations could be considerable, according to Eugene Braunwald who chaired the session. In Munich they talked with Peter Goodwin.
    LSHTM Audio News»
    Bayard Roberts, Siân Clarke, Sandy Cairncross, Claire Bertschinger and Virginia Berridge
    Derek Thorne and Peter Goodwin talk with Bayard Roberts, Siân Clarke, Sandy Cairncross, Claire Bertschinger and Virginia Berridge of The London School of Hygiene and Tropical Medicine about:
    - depression and post traumatic stress disorder in war-torn northern Uganda and the lessons to be drawn from a research project there; - the unexpected additional value of using malaria drugs at regular intervals among school children in Kenya; - the key role of sanitation in preventing infant deaths all over the world and what is being done to improve it; - the life and work of the nurse who inspired Band Aid and Live Aid, as she receives an honorary doctorate; - the \"marketing\" of health to the British public, as illustrated by the way attitudes to smoking have changed over the years.
    Subscribe to Audio Medica Podcast